Use of Tofacitinib in the Context of COVID-19 Vaccination: Comment on the American College of Rheumatology Clinical Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases

Arthritis Rheumatol. 2021 Sep;73(9):1768-1769. doi: 10.1002/art.41806. Epub 2021 Jul 29.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • Piperidines
  • Pyrimidines
  • Rheumatic Diseases* / drug therapy
  • Rheumatology*
  • SARS-CoV-2
  • United States
  • Vaccination

Substances

  • COVID-19 Vaccines
  • Piperidines
  • Pyrimidines
  • tofacitinib

Grants and funding